User profiles for Anne Sofie Andreasen

Anne Sofie Andreasen

Senior consultant, Herlev University Hospital, Associate Professor, University of …
Verified email at regionh.dk
Cited by 1020

[HTML][HTML] Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults

…, FWJ Van Den Berg, DS Nielsen, AS Andreasen… - PloS one, 2010 - journals.plos.org
Background Recent evidence suggests that there is a link between metabolic diseases and
bacterial populations in the gut. The aim of this study was to assess the differences between …

Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects

AS Andreasen, N Larsen… - British journal of …, 2010 - cambridge.org
According to animal studies, intake of probiotic bacteria may improve glucose homeostasis.
We hypothesised that probiotic bacteria improve insulin sensitivity by attenuating systemic …

[HTML][HTML] Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID …

…, M Smitt, MH Bestle, AS Andreasen… - Intensive care …, 2022 - Springer
Purpose We compared dexamethasone 12 versus 6 mg daily for up to 10 days in patients
with coronavirus disease 2019 (COVID-19) and severe hypoxaemia in the international, …

[HTML][HTML] Type 2 diabetes is associated with altered NF-κB DNA binding activity, JNK phosphorylation, and AMPK phosphorylation in skeletal muscle after LPS

AS Andreasen, M Kelly, RMG Berg, K Møller… - PloS one, 2011 - journals.plos.org
Systemic inflammation is often associated with impaired glucose metabolism. We therefore
studied the activation of inflammatory pathway intermediates that interfere with glucose …

Low‐dose hydrocortisone in patients with COVID‐19 and severe hypoxia: The COVID STEROID randomised, placebo‐controlled trial

…, T Benfield, CS Ulrik, AS Andreasen… - Acta …, 2021 - Wiley Online Library
Background In the early phase of the pandemic, some guidelines recommended the use of
corticosteroids for critically ill patients with COVID‐19, whereas others recommended against …

[HTML][HTML] Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia

…, M Smitt, MH Bestle, AS Andreasen… - Intensive care …, 2022 - Springer
Purpose We assessed long-term outcomes of dexamethasone 12 mg versus 6 mg given
daily for up to 10 days in patients with coronavirus disease 2019 (COVID-19) and severe …

Lower vs higher oxygenation target and days alive without life support in COVID-19: The HOT-COVID randomized clinical trial

…, UG Pedersen, O Mathiesen, AS Andreasen… - JAMA, 2024 - jamanetwork.com
Importance Supplemental oxygen is ubiquitously used in patients with COVID-19 and severe
hypoxemia, but a lower dose may be beneficial. Objective To assess the effects of targeting …

Haloperidol vs. placebo for the treatment of delirium in ICU patients: a pre-planned, secondary Bayesian analysis of the AID–ICU trial

…, G Citerio, MO Collet, SO Weber, AS Andreasen… - Intensive Care …, 2023 - Springer
Purpose The AID–ICU trial was a randomised, blinded, placebo-controlled trial investigating
effects of haloperidol versus placebo in acutely admitted, adult patients admitted in …

Low‐dose hydrocortisone in patients with COVID‐19 and severe hypoxia (COVID STEROID) trial—Protocol and statistical analysis plan

…, T Benfield, CS Ulrik, AS Andreasen… - Acta …, 2020 - Wiley Online Library
Introduction Severe acute respiratory syndrome coronavirus‐2 has caused a pandemic of
coronavirus disease (COVID‐19) with many patients developing hypoxic respiratory failure. …

Type 2 diabetes mellitus is associated with impaired cytokine response and adhesion molecule expression in human endotoxemia

AS Andreasen, T Pedersen-Skovsgaard… - Intensive care …, 2010 - Springer
Purpose Type 2 diabetes is associated with an increased risk of acquiring infectious diseases
and developing sepsis. This may partly be due to immune dysfunction. We investigated …